Get access

Pegylated interferon for chronic hepatitis B

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the beneficial and harmful effects of pegylated interferon alpha-2a (40 kilodalton (kd)) or pegylated interferon alpha-2b (12 kd) alone or in combination with other drugs, as compared with no treatment, placebo, or other antiviral drugs (except adefovir dipivoxil) for chronic hepatitis B, with HBeAg-positive or HBeAg-negative status.

Ancillary